Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

51.18
-0.0850-0.17%
Volume:588.46K
Turnover:30.01M
Market Cap:4.06B
PE:6.81
High:51.81
Open:51.04
Low:49.86
Close:51.26
Loading ...

PTC Therapeutics Swings to Q1 Earnings, Revenue Increases

MT Newswires Live
·
07 May

PTC Therapeutics Inc : RBC Raises Target Price to $58 From $57

THOMSON REUTERS
·
07 May

PTC Therapeutics (PTCT) Q1 2025 Earnings Call

Motley Fool Transcribing
·
07 May

PTC Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

PTC Therapeutics Q1 EPS $10.04, Sales $1.18B

Benzinga
·
07 May

Stock Track | PTC Therapeutics Plummets 11.37% Following Q1 Earnings Release and Lukewarm Analyst Ratings

Stock Track
·
07 May

PTC Therapeutics: Positive Chmp Opinion for Sephience (Sepiapterin) Received in April 2025, Nda Review Remains on Track for July 29, 2025 Pdufa Date

THOMSON REUTERS
·
07 May

PTC Therapeutics Inc: NOW Anticipates Full-Year 2025 Revenue to Be Between $650 Mln and $800 Mln

THOMSON REUTERS
·
07 May

Scotiabank Keeps Their Hold Rating on PTC Therapeutics (PTCT)

TIPRANKS
·
06 May

Hold Rating for PTC Therapeutics Amid Mixed Clinical Results and Uncertain FDA Approval Prospects

TIPRANKS
·
06 May

Why Did PTC Therapeutics Stock Fall On Monday Despite Mid-Stage Study For Huntington's Hits Primary Goal?

Benzinga
·
06 May

Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), PTC Therapeutics (PTCT) and Larimar Therapeutics (LRMR)

TIPRANKS
·
06 May

BUZZ-U.S. STOCKS ON THE MOVE-Airline stocks, Wendy's, Skechers

Reuters
·
05 May

RBC Capital Adjusts PTC Therapeutics Price Target to $57 From $65, Maintains Outperform Rating

MT Newswires Live
·
05 May

PTC Therapeutics Shares Drop 21% After Co Reports Mid-Stage Data for Neurological Disease Drug

THOMSON REUTERS
·
05 May

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Agilent (A), Andlauer Healthcare Group (OtherANDHF) and PTC Therapeutics (PTCT)

TIPRANKS
·
05 May

Sector Update: Health Care Stocks Decline Pre-Bell Monday

MT Newswires Live
·
05 May

BUZZ-U.S. STOCKS ON THE MOVE-Stardust Power, Peabody, On Semiconductor

Reuters
·
05 May

BUZZ-PTC Therapeutics falls after mid-stage data for Huntington's disease drug

Reuters
·
05 May

PTC Therapeutics Says Phase 2 Votoplam Trial in Huntington's Disease Meets Primary Endpoint

MT Newswires Live
·
05 May